Predictable excess hepatotoxicity in the SimpliciTB trial - Authors' reply

Lancet Infect Dis. 2024 Dec;24(12):e728. doi: 10.1016/S1473-3099(24)00718-7. Epub 2024 Oct 28.

Authors

Muge Cevik¹, Maria Beumont², Eugene Sun², Derek J Sloan³, Stephen H Gillespie³

Affiliations

¹ Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK. Electronic address: mc349@st-andrews.ac.uk.
² TB Alliance, New York, NY, USA.
³ Division of Infection and Global Health Research, School of Medicine, University of St Andrews, St Andrews KY16 9TF, UK.

PMID: 39481422
DOI: 10.1016/S1473-3099(24)00718-7

No abstract available

Publication types

Letter